SciSight Ecosystem
WoS SCIE Q4Scopus Q2SCImago #11,038CAS 4区Review JournalHybrid

Current Stem Cell Research & Therapy

Abbreviation (ISO):CURR STEM CELL RES T
Country: United Arab Emirates•WoS SCIE Quartile: Q4•Scopus SJR: 0.538•SCImago Rank: #11,038•Identifier (ISSN):1574-888X(Print)/2212-3946(Online)•Articles / Year: 84•Estimated Publication Fee (APC): $2,975 USD
Clarivate IF (2026)Q4
2.1
↓ -0.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
43

43 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
84articles/year
3.9% Gold OA•18.03% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q4(IF: 2.1)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.00đ
WoS Q4(IF: 2.1)
🔵 Computed
20251.00đ
WoS Q4(IF: 2.2)
🔵 Computed
20241.00đ
WoS Q4(IF: 2.1)
🔵 Computed
20231.00đ
WoS Q4(IF: 2.7)
🔵 Computed
20221.00đ
WoS Q4(IF: 3.758)
🔵 Computed
20211.00đ
WoS Q4(IF: 3.828)
🔵 Computed
20201.00đ
WoS Q4(IF: 2.614)
🔵 Computed
20191.00đ
WoS Q4(IF: 2.612)
🔵 Computed
20181.00đ
WoS Q4(IF: 2.168)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Current Stem Cell Research & Therapy publishes high quality frontier reviews, drug clinical trial studies and guest edited issues on all aspects of basic research on stem cells and their uses in clinical therapy. The journal is essential reading for all researchers and clinicians involved in stem cells research.

Topics Covered (Recognized by AI)
Biology89.9%Genetics86.4%Medicine81.7%Cell biology81.4%Chemistry71.8%Biochemistry70%Stem cell69.6%Internal medicine62.6%Pathology58.4%Gene45.1%Mesenchymal stem cell39.3%Cell35.1%Surgery34.3%Immunology33.6%Psychology24.5%Cancer research24.2%In vitro24.1%Embryonic stem cell23.5%Regeneration (biology)23%Transplantation22.9%

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,038Scopus Q2SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.538

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
67

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.39

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,975 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations680
3-Year Documents284
Citable Documents280

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区CELL & TISSUE ENGINEERING
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Bentham Science Publishers B.V.
Publication Language
English
Frequency
Periodic
Editorial Address
EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
CELL & TISSUE ENGINEERING
JCRSCIE
26/32Q4
CELL BIOLOGY
JCRSCIE
171/207Q4
CELL & TISSUE ENGINEERING
JCISCIE
30/32Q4
CELL BIOLOGY
JCISCIE
178/207Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—374
20252.25465
20242.183189
20232.7117613
20223.758140980
20213.82893873
20202.6141151,402
20192.612801,524
20182.168852,416
2017—682,000
2016—1092,457
2015—651,096
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Current Stem Cell Research & Therapy

WoS Q4
1245201820192020202120222023202420252.20
Annual Impact Factor Metric
2025:2.2

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 3e178b01-e1c1-43df-b773-baa8b6502891
Database Updated: 2026-09-29